Why weight-loss jabs work better for some people than others
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs such as Wegovy and Mounjaro to treat obesity, research suggests.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
No locations linked to this story
All Coverage
People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs such as Wegovy and Mounjaro to treat obesity, research suggests.
Similar Stories
Related coverage based on topic and tags
Eli Lilly launches oral weight-loss pill Foundayo in UK - Reuters
Eli Lilly launches oral weight-loss pill Foundayo in UK Reuters
August 23, 2026 at 11:07 PMWeekly type 2 diabetes jab could replace daily injections
Hundreds of thousands of people with type 2 diabetes could get access to a new weekly insulin jab to replace daily injections.
August 20, 2026 at 12:39 AMMore US employers to drop weight-loss drugs in 2027, as healthcare costs increase - Reuters
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase Reuters
August 25, 2026 at 03:46 PMChina's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
August 27, 2026 at 03:47 AMNicotine vapes best chance to quit smoking, major review finds
They work better than patches, gum or pills, the most up-to-date evidence suggests.
August 25, 2026 at 11:40 PMUS FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
August 28, 2026 at 06:38 PM